AMY RANDOLPH: Open Payments
NPI 1285019000 · GASTONIA, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,530 in 73 payments from 26 companies in 2025. Trend: 2023 $0 · 2024 $619 · 2025 $1,530
Food & beverage: $1,530
| Company | Payments | Amount |
|---|---|---|
| Regeneron Healthcare Solutions, Inc. | 7 | $171 |
| GlaxoSmithKline, LLC. | 9 | $163 |
| Verona Pharma, Inc. | 7 | $150 |
| Lilly USA, LLC | 5 | $92 |
| Actelion Pharmaceuticals US, Inc. | 3 | $91 |
| Pulmonx Corporation | 2 | $91 |
| Novo Nordisk Inc | 4 | $79 |
| AstraZeneca Pharmaceuticals LP | 4 | $75 |
| Avadel CNS Pharmaceuticals, LLC | 3 | $72 |
| Viatris Specialty LLC | 4 | $68 |
Products named: DUPIXENT, Ohtuvayre, CHARTIS CATHETER, NUCALA, TRELEGY ELLIPTA, LUMRYZ, YUPELRI, OPSUMIT.
Industry payments across NC — which companies pay providers there.
